Literature DB >> 35699785

Microcystic stromal tumor of the ovary: a recurrent case with somatic CTNNB1 missense mutation.

Naoki Kojima1, Hiroshi Yoshida2, Masaya Uno3, Kengo Hiranuma4, Tomoaki Naka1, Kouya Shiraishi4, Tomoyasu Kato3.   

Abstract

Microcystic stromal tumors (MCSTs) of the ovary are rare sex cord-stromal tumors that are considered benign neoplasms because almost all cases display unilateral, localized lesions and have benign outcomes, except for one recurrent case with familial adenomatous polyposis and another initial metastatic case with a CTNNB1 mutation. We report herein a sporadic case that relapsed as intra-abdominal spread 9 years and 1 month after primary left salpingo-oophorectomy for torsion of the ovarian tumor pedicle. The tumor relapsed as multiple disseminations at the subabdominal wall, Douglas pouch, and omentum. Histologically, the tumor cells formed microcysts and infiltrated the surrounding adipose tissue, similar to the invasive implants of ovarian epithelial borderline tumors. Mutation analysis of the recurrent tumor revealed a somatic CTNNB1 p.S33Y activated missense mutation and a germline KDR p.Q472H variant. In conclusion, long-term clinical follow-up may be needed to detect any recurrence of MCST, irrespective of familial adenomatous polyposis.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  CTNNB1; KDR; Microcystic stromal tumor; Ovary; Recurrence; Sex cord-stromal tumor

Year:  2022        PMID: 35699785     DOI: 10.1007/s00428-022-03360-1

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  3 in total

1.  Ovarian microcystic stromal tumors: clinical, radiological, and pathological studies of two cases.

Authors:  Jing Liu; Yuanyuan Hou; Lei Bao; Xiuli Wang; Fang Wang; Lei Jiang; Yonghua Chen; Zenghui Li; Guohua Yu; Yongli Chu
Journal:  Int J Clin Exp Pathol       Date:  2019-06-01

Review 2.  CTNNB1 Mutations in Ovarian Microcystic Stromal Tumors: Identification of a Novel Deletion Mutation and the Use of Pyrosequencing to Identify Reported Point Mutation.

Authors:  Kiyong Na; Eun Kyung Kim; Wonjun Jang; Hyun-Soo Kim
Journal:  Anticancer Res       Date:  2017-06       Impact factor: 2.480

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.